Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-22-072191

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Walts Alan Edmund Director 2022-06-15 Grant or award · Stock Options (Right to Buy) +20,000 20,000 D
Loading xslF345X03/tm2218714-8_4seq1.xml…